- Home
- OPXS vs ALXO Comparison
OPXS vs ALXO Comparison
Compare OPXS & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- ALXO
- Stock Information
- Founded
- OPXS 1987
- ALXO 2015
- Country
- OPXS United States
- ALXO United States
- Employees
- OPXS N/A
- ALXO N/A
- Industry
- OPXS Electronic Components
- ALXO Biotechnology: Pharmaceutical Preparations
- Sector
- OPXS Technology
- ALXO Health Care
- Exchange
- OPXS Nasdaq
- ALXO Nasdaq
- Market Cap
- OPXS 89.0M
- ALXO 79.7M
- IPO Year
- OPXS N/A
- ALXO 2020
- Fundamental
- Price
- OPXS $13.72
- ALXO $1.47
- Analyst Decision
- OPXS
- ALXO Strong Buy
- Analyst Count
- OPXS 0
- ALXO 6
- Target Price
- OPXS N/A
- ALXO $3.30
- AVG Volume (30 Days)
- OPXS 38.8K
- ALXO 356.5K
- Earning Date
- OPXS 12-18-2025
- ALXO 11-07-2025
- Dividend Yield
- OPXS N/A
- ALXO N/A
- EPS Growth
- OPXS 23.32
- ALXO N/A
- EPS
- OPXS 0.75
- ALXO N/A
- Revenue
- OPXS $39,481,000.00
- ALXO N/A
- Revenue This Year
- OPXS N/A
- ALXO N/A
- Revenue Next Year
- OPXS N/A
- ALXO N/A
- P/E Ratio
- OPXS $18.09
- ALXO N/A
- Revenue Growth
- OPXS 21.00
- ALXO N/A
- 52 Week Low
- OPXS $5.36
- ALXO $0.40
- 52 Week High
- OPXS $17.76
- ALXO $2.27
- Technical
- Relative Strength Index (RSI)
- OPXS 43.35
- ALXO 49.39
- Support Level
- OPXS $12.50
- ALXO $1.29
- Resistance Level
- OPXS $14.13
- ALXO $1.56
- Average True Range (ATR)
- OPXS 1.01
- ALXO 0.18
- MACD
- OPXS -0.25
- ALXO 0.01
- Stochastic Oscillator
- OPXS 29.37
- ALXO 65.90
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.